Approach to Equivocal Dexamethasone Suppression Test
When faced with an equivocal dexamethasone suppression test (DST), perform a second different screening test—either 24-hour urinary free cortisol (UFC), late-night salivary cortisol (LNSC), or midnight serum cortisol—and if results remain discordant, consider the dexamethasone-CRH test to definitively rule out Cushing's syndrome. 1
Initial Assessment of the Equivocal Result
Before proceeding with additional testing, verify the validity of your DST result:
Measure dexamethasone levels at the time of cortisol measurement to exclude false-positive results from malabsorption, rapid metabolism, or non-compliance 2, 3. A dexamethasone level below 4.5 nmol/L suggests inadequate bioavailability and invalidates the test 3.
Review medications: CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort) accelerate dexamethasone clearance causing false-positives; conversely, fluoxetine, cimetidine, or diltiazem inhibit metabolism causing false-negatives 2, 4
Check for CBG alterations: Oral estrogens, pregnancy, or chronic active hepatitis increase corticosteroid-binding globulin, elevating total cortisol and causing false-positives 2
Algorithmic Approach to Equivocal Results
Step 1: Perform a Second Screening Test
The Endocrine Society guidelines strongly recommend performing another high-sensitivity test when initial results are abnormal 1:
24-hour UFC (2-3 collections): Advantages include independence from CBG changes and dexamethasone compliance. Avoid in renal impairment (CrCl <60 mL/min) or polyuria (>5 L/24h) 2
Late-night salivary cortisol (LNSC): Multiple collections particularly useful for detecting cyclic Cushing's syndrome. Avoid in night-shift workers or those with disrupted sleep-wake cycles 2
Midnight serum cortisol: Cumbersome but useful in specific situations; cutoff of 7.5 μg/dL has 87% specificity 1
Step 2: Interpret Combined Results
Concordantly positive (both tests abnormal): Proceed to establish the cause of Cushing's syndrome, provided pseudo-Cushing's states (psychiatric disorders, alcohol use, obesity) have been excluded 1
Concordantly negative (both tests normal): Stop further testing unless cyclic Cushing's syndrome is suspected 1
Discordant results (one positive, one negative): This is your equivocal scenario requiring further evaluation 1
Step 3: For Persistent Discordant Results—The Dexamethasone-CRH Test
The dexamethasone-CRH test is specifically recommended for equivocal UFC results and discordant screening tests 1. This test has 98% sensitivity and 94% specificity when combined with low-dose DST criteria 5.
Protocol: Administer 48-hour low-dose dexamethasone (0.5 mg every 6 hours), then give CRH (1 μg/kg IV) 2 hours after the last dexamethasone dose. Measure cortisol 15 minutes post-CRH 1
Critical caveats:
- Measure dexamethasone level at CRH administration to exclude false-positives 1
- Ensure cortisol assay accuracy at low detection levels 1
- The 2-hour interval between dexamethasone and CRH is critical for compliance 1
Important Pitfalls to Avoid
False reassurance from "normal" DST: Up to 18% of patients with proven Cushing's disease suppress cortisol to <5 μg/dL on 1-mg overnight DST, and 8% suppress to <2 μg/dL 6. The 2-day low-dose DST yields false-negatives in 28-38% of cases 6. Never use DST as the sole criterion to exclude Cushing's syndrome.
Pseudo-Cushing's states: Psychiatric disorders, alcohol use, obesity, and polycystic ovary syndrome activate the HPA axis and produce mildly abnormal results (UFC typically <3-fold normal) 2. Consider treating underlying conditions and retesting when resolved 1.
Cyclic Cushing's syndrome: If clinical suspicion remains high despite negative tests, perform multiple sequential LNSC or UFC collections over weeks to months to capture episodic hypercortisolism 2, 1
When High Pretest Probability Persists
If clinical features strongly suggest Cushing's syndrome despite equivocal biochemistry:
- Refer to endocrinology for expert evaluation 1
- Consider active follow-up with repeat testing in 6 months if symptoms progress 1
- Reassure the patient that mild hypercortisolism poses minimal immediate risk during the evaluation period 1
The most recent Lancet Diabetes & Endocrinology consensus (2021) emphasizes that cortisol <1.8 μg/dL (50 nmol/L) after 1-mg DST strongly predicts absence of Cushing's syndrome, while values >5 μg/dL (138 nmol/L) generally identify dysregulated cortisol secretion 2. Values between these thresholds represent the equivocal zone requiring the systematic approach outlined above.